Charité-Campus Benjamin Franklin, Medizinische Klinik I (Gastroenterologie, Infektiologie, Rheumatologie), Berlin, Germany.
Eur J Immunol. 2010 Nov;40(11):3128-37. doi: 10.1002/eji.201040701. Epub 2010 Oct 19.
Oral antigen uptake can induce systemic immune responses ranging from tolerance to immunity. However, the underlying mechanisms are poorly understood, especially in humans. Here, keyhole limpet hemocyanin (KLH), a neoantigen which has been used in earlier studies of oral tolerance, was fed in a repeated low-dose and a single high-dose protocol to healthy volunteers. KLH-specific CD4(+) T-cell proliferation and cytokine production, as well as KLH-specific serum Ab and the effects of oral KLH on a subsequent parenterally induced systemic immune response, were analyzed. Repeated low-dose oral KLH alone induced antigen-specific CD4(+) T cells positive predominantly for the gut-homing receptor integrin β7 and the cytokines IL-2 and TNF-α; some CD4(+) T cells also produced IL-4. Oral feeding of KLH accelerated a subsequent parenterally induced systemic CD4(+) T-cell response. The cytokine pattern of KLH-specific CD4(+) T cells shifted toward more IL-4- and IL-10- and less IFN-γ-, IL-2- and TNF-α-producing cells. The parenterally induced systemic KLH-specific B-cell response was accelerated and amplified by oral KLH. The impact of single high-dose oral KLH on antigen-specific immune responses was less pronounced compared with repeated low-dose oral KLH. These findings suggest that oral antigen can effectively modulate subsequently induced systemic antigen-specific immune responses. Immunomodulation by oral antigen may offer new therapeutic strategies for Th type1-mediated inflammatory diseases and for the development of vaccination strategies.
口服抗原摄取可诱导从耐受到免疫的全身免疫反应。然而,其潜在机制尚不清楚,尤其是在人类中。在这里,兰蛤血蓝蛋白(KLH),一种在口服耐受的早期研究中使用过的新抗原,以重复低剂量和单次高剂量方案给予健康志愿者。分析了 KLH 特异性 CD4(+)T 细胞增殖和细胞因子产生,以及 KLH 特异性血清 Ab 和口服 KLH 对随后的全身免疫反应的影响。单独重复低剂量口服 KLH 可诱导主要表达肠道归巢受体整合素β7 和细胞因子 IL-2 和 TNF-α的抗原特异性 CD4(+)T 细胞;一些 CD4(+)T 细胞也产生 IL-4。口服 KLH 可加速随后的全身 CD4(+)T 细胞反应。KLH 特异性 CD4(+)T 细胞的细胞因子模式向产生更多的 IL-4 和 IL-10、更少的 IFN-γ、IL-2 和 TNF-α的细胞转移。口服 KLH 加速并放大了全身 KLH 特异性 B 细胞反应。单次高剂量口服 KLH 对抗原特异性免疫反应的影响不如重复低剂量口服 KLH 明显。这些发现表明口服抗原可以有效地调节随后诱导的全身抗原特异性免疫反应。口服抗原的免疫调节可能为 Th1 型介导的炎症性疾病和疫苗接种策略的发展提供新的治疗策略。